Skip to main content

Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association 

Written by Customer Service on . Posted in Public Companies.

SOUTH JORDAN, Utah, Nov. 22, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced that Fred Lampropoulos, Merit’s Chairman and CEO, received the 2022 Manufacturing Leader of the Year Award in the large manufacturing category from the Utah Manufacturers Association. The award honors excellence and tremendous efforts made by outstanding leaders and companies in the state of Utah. Mr. Lampropoulos accepted the award at a ceremony held at The Little America Hotel in Salt Lake City, UT.

Mr. Lampropoulos founded Merit over thirty years ago, and the company has become a leader in the manufacturing industry, designing and manufacturing lifesaving medical devices in Utah ever since. As Merit grew, its manufacturing footprint expanded to include facilities around the globe. Operational excellence is essential to Merit’s success. Each of its manufacturing facilities maintains one or more ISO certifications—international gold standards agreed upon by industry experts—in the areas of environment, energy, and occupational health and safety management. This design and manufacturing strategy has helped Merit grow to become one of the largest companies in Utah, broadening its global presence and helping it reach more than $1 billion in revenue. 

“This award acknowledges Fred’s significant leadership in our industry,” said Todd Bingham, President, and CEO of the Utah Manufacturers Association. “He is a pillar of the community and sets an example that many organizations look up to.”

Upon receiving the award, Mr. Lampropoulos said, “I am honored to accept this award on behalf of the entire Merit family. This award recognizes their hard work and dedication.” He added, “Receiving this award is especially meaningful, as it has been a challenging year for manufacturers. We have faced supply chain interruptions, which only spurred us to find innovative ways to produce more of our own materials. By pivoting distribution efforts, we continued to deliver products to our customers, providing them with the solutions they need to care for their patients.”

ABOUT MERIT MEDICAL  
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 600 individuals. Merit employs approximately 6,800 people worldwide.

TRADEMARKS  
Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.  
  
CONTACTS  
PR/Media Inquiries  
Sarah Comstock 
Merit Medical  
+1-801-432-2864 | sarah.comstock@merit.com 
  
Investor Inquiries  
Mike Piccinino, CFA, IRC  
Westwicke – ICR  
+1-443-213-0509 | mike.piccinino@westwicke.com  

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.